Well maybe https://www.fiercebiotech.com/biotech/pfizers-obesity-pill-news-leaves-analysts-wanting-biotech-investors-cheering?oly_enc_id=4924G0643390I0A

Me too. I do expect there will be.

Is that short for Delivery Boy? Well, whatever!
All have a blessed weekend.
TICK TICK TICK ..... money in the bank and trials in the works together with some new pharma company raring to go.

Glad for the chance to have grabbed some more $NSAV$

Looking good, I knew it would!!

Who were you previously to getting banned?

If Gold continues and goes to 4 grand an ounce. The mill will be running ore under .333 oz per ton and making plenty. Should that happen the mill will have to be expanded beyond 24 hours a day perhaps having to double the capacity.

"Metallurgical analyses are currently underway to determine composition and make-up of material including final grind and confirmation of efficacy of selected frothing agent and flocculent in the flotation cells."

Patience is taught by trading the OTC. Glad we have the 4July holiday passed.

Could be GrabNterd et al are diluting like crazy. He does a great job pumping this up. So far he deserves a crossbow shot between the eyes.
I also notice on more than a few occasions that my orders to buy or sell get passed over unfilled. No manipulation? Wow, big time. I like the tech but there is nothing to like about the disdain for shareholders.

Is it possible to buy this ticker without having to pay a foreign commission of $50 if using Fidelity and living in US?

I think the CEO is going to re-emerge. Maybe not but if there is a hint he might....guess what?

I will try to be in a great position should this in fact make a come back. No hurry. Patience has been a moneymaker here thus far after pivoting away from the tattoo baby.

Something I learned long ago. Assume very little, but do assume there are abusive shorts. To find big channels look for the bashers. When they come out of the woodwork like termites ready to breed, that is the time to get ready to buy buy buy.

Come on termites!! Chomp chomp

Thanks!

Just wait for the investor video....coming as soon as first pour. Boom

Buying opportunity. Balls and patience. I bought this at this point and lower with less info. I like it much better now.

I rest my case too. Buenas noches.

The patent lawsuit in Germany will chop Pfizer down to size if this doesn't work out in their favor. This bears paying close attention.

How's the crow tasting?

Smart pivot IMO. The health sector is too capital and human intensive plus having to navigate in a corrupted Health System of pay to play and more.

"With the acquisition of Advanced Executive Sales LLC, the Company is expected to have 2024 annual revenues of over $25,000,000. The Company intends to shift its primary focus to the financial services sector and grow revenue and net asset value through organic growth and additional acquisitions utilizing shares of its common stock, non-convertible promissory performance-based notes, and cash as available."

You post BS. Made up stuff like you know what you are talking about. What a joke.
Pretty simple so you know the facts. I think the CEO is going to re-emerge. Maybe not but
I will try to be in a great position should this in fact make a come back. No hurry. Patience has been a moneymaker here thus far after pivoting away from the tatoo baby. When you want a trading lesson, let me know.

Something I learned long ago. Assume very little but do assume there are abusive shorts.

Should it dip below 10 thinking to re-enter.

LMAO, sure you do.

TÜBINGEN, Germany/BOSTON, USA – July 11, 2024 – CureVac N.V. (Nasdaq: CVAC) (“CureVac”), a global biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid (“mRNA”), today announced the latest trial dates for its ongoing patent litigation against Pfizer/BioNTech in multiple geographies including the U.S., UK and Germany.



The U.S. trial against Pfizer/BioNTech will take place on March 3, 2025, before the U.S. District Court of the Eastern District of Virginia. A previously issued court recommendation to stay the proceedings for all 10 U.S. patents was withdrawn. The recommendation had followed a motion by Acuitas Therapeutics to intervene, sever and stay proceedings based on co-owner and co-inventorship claims. It was resolved after both companies reached a settlement in April 2024, which provided Acuitas licenses to several patents, including three out of four disputed U.S. patents. These three patents have been withdrawn from the U.S. patent litigation against Pfizer/BioNTech. In return, Acuitas acknowledges that CureVac is the sole owner of the disputed patents.



Litigation in Europe will continue March 25, 2025, with a hearing on the validity of EP 3 708 668 B1 (split poly-A tail technology), before the Opposition Division of the European Patent Office. The infringement action in relation to this patent was previously suspended pending the validity determination by the European Patent Office. In the German patent litigation against Pfizer/BioNTech, the settlement with Acuitas Therapeutics led to the withdrawal of two utility models covering equivalent claims to the three patents withdrawn in the United States. As previously announced, a hearing before the infringement court of Düsseldorf covering the European patent EP 4 023 755 B1 (split poly-A tail technology) and the utility model DE 20 2021 004 130 U1 (COVID-19 vaccine design), is scheduled for September 10, 2024.



Furthermore, a trial in the UK has started on July 10, 2024. It is based on a declaration of non-infringement and request for revocation by Pfizer/BioNTech in the UK for the two CureVac patents EP 3 708 668 B1 and EP 4 023 755 B1 (split poly-A-tail technology). CureVac counterclaimed for infringement. A judgement is expected later in 2024. The trial for the further involved patent EP 1 857 122 B1 (G/C enrichment technology) will be set for a later time point.

No not at all. No one believes you for making up lies about other traders and pretending you know when they bought and sold. Such contortions of reality on a consistent basis by one who does not claim to own the stock is sheer falsity (fantasy). Or are you just trying to snare me and others in falsehood so as to appear superior?

It used to be funny stuff. Enough already, it now borders on the weird.

I hope the oral version has better efficacy than the Covid Paxlovid.

Wonder if he was one of the lucky ones working at Pfizer who did not choose the jab? Could be he took that special jab not offered to the public similar to the ones offered to Pfizer employees over in Australia. Who knows what is he feeling or thinking. Could be he is suffering and wants to play hard with his blood money before his next infarction. Hard to say. For his sake I hope his conscious is clean and his health is good. Amen.

Oh that was a lovely channel. Perhaps let's call it Channel #5. The one that was so sweet to me riding up down the channel, but DJ would not budge and missed out soooo many times. Sad. Well, hang around and learn. There may be some more sweet smelling Channel on the horizon. Will let you know. But first, one must learn how to read and play and speak without doing the limbo too low. Say, do you think shortie covered yet? LMAO

And 90% green. Even my few shorts made money....especially the jab stocks.
Green is good.
Now with this one... it all depends on the final outcome of the legal junk and how it proceeds from there.
Tempted to buy in again. I hold a few still just to keep an eye on it. So far so good even still!!
I am rooting for Mick. Let's see how it goes. I would love to pile back in. Waiting....

Good bear hunting!!

Yes, and he speaks clearly and can find his way off the drilling platform without getting lost or falling down. He has my vote.

Seems some are scared listless with continuous lying posts on purpose.
This is a good moment to add.

Look at my recommendations to DJ... on track and always a money maker. It's all in the timing not in phony analysis. It's called channel trading. Anyone can make a buck. Try it, it is a winnable solution.

https://stockanalysis.com/stocks/cydy/
"The terms of the settlement provide an immediate influx of non-dilutive cash and eliminates $14 million of accounts payable. Importantly, the settlement ends the potential distraction and uncertainty associated with protracted litigation and allows the Company to immediately advance its clinical trials and research and development initiatives, said Dr. Jacob Lalezari, CEO.”

TIck TIck Tick..... Sidley pre-paid, thanks!, 6.5 $$$ million bond released, thanks!,14$$milly eliminated, thanks!, 12$$ milly influx, thanks Kareem, 32.5 $$ milly credited to our account!! Plus the earlier Samsung agreement... I WOULD SAY WE ARE GOOD TO GO TRIAL WISE!! new partner ???

$$CYDY$$ 2024

VANCOUVER, Washington, June 27, 2024 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTCQB: CYDY) ("CytoDyn" or the "Company"), a biotechnology company developing leronlimab, a CCR5 antagonist with the potential for multiple therapeutic indications, announced today that its preclinical MASH study with SMC Laboratories, Inc. (“SMC”) has commenced, with results expected in the fall of 2024.

CytoDyn believes its prior MASH study demonstrated a statistically significant benefit of leronlimab at a dosing level of 350 mg. To clarify the optimal dosing and evaluate the potential for combination therapy, SMC will be conducting a twelve-week preclinical mouse study evaluating both 350 and 700 mg dose levels, alone and in combination with Resmetirom, a drug recently approved by the FDA. The study will evaluate leronlimab’s potential role in preventing and/or reversing liver fibrosis.

CytoDyn’s CEO, Dr. Jacob Lalezari, stated, “in addition to clarifying dosing and efficacy, the goal of this study is to eventually use the results to pursue partnerships in the MASH space. Although CytoDyn will be primarily focused on oncology and inflammation in the coming months, we do believe that leronlimab could have a significant role in the treatment of MASH, whether as a standalone therapeutic or in a combination therapy approach.”

We are grateful having boots on the ground. Keep on keeping on!

right on. bot and buying more.

Ugandan military conscripted him and he is now in Haiti trying to restore order.

Made good bank on NVAX to make up for my losses here. Still hold a few at 3.91, sold at 15.26. Will jump back in under $10 as the shorts are piling on still.
As to the jab, no thanks, not any of any kind especially mRNA variety. Knowing what you put in your body is more important than being right or wrong in the highly manipulated stock market. After intense scrutiny and many years of researching TCM, I would certainly take the products offered by Todos and never take the jabs.
Due diligence pays especially for anyone who desired to live longer and healthier.

Jay is a mover and shaker. I like his fighting spirit and savvy as to how the health system functions and malfunctions. This is the leadership we have needed to advance leronlimab. With his team we have seen great strides in the past year. The PPS is going to go nuts when new trials begin.

We all know it's coming especially the shorts. There will be some big money entering the scene which will set off a short squeeze. Some large buys are being noted. Whether the pps goes up or down a few points with the same typical volume is meaningless. Yesterday especially but for the past week or so, the pps has steadily inched up having observed a changing behavior. Astute and aware traders and investors are again entering. On this forum we will see some new faces appear and some others from the past return. We all have known it is just a matter of time, those who truly know and appreciate our candidate leronlimab.

The recognition of the sthenic immense talent of Dr. Jay Lalezari by Board Chair Tanya Urbach has been key to this turn around. Leadership is everything. With leronlimab as our product great advances are in store. We are truly blessed to be part of this history.

This is a good time to re-familiarize with all the talent we possess. Read the website and know those involved in your company. Know what you own. $CYDY$ 2024

Who would consent knowing this?
https://petermcculloughmd.substack.com/p/a-pandoras-box-in-the-pharma-lab?publication_id=1119676&post_id=146401978&triggerShare=true&isFreemail=true&r=x7hm&triedRedirect=true
Well, PFE just shoots from the hip. No toxicology studies? OMG
Oh heck, they mean well. Guess I'll just bend over.

Knowing some of the facts that have been exposed....who in their right mind would invest in this company except to squeeze some profit from the pps movement?

Hope they don't explode!

California needs a gold rush. So much money is relocating out of state. Especially now seeing the green dream is no longer supreme.

Here's to some rip snorter rain and snow storms. Nothing like God's erosion machine to reveal some hidden nuggets.

So we can expect a ProActive Video interview update once the mill is fired up and the first gold runs have begun. That should be coming fairly soon.